Construction on the new research and development center that cancer test maker Exact Sciences Corp. announced Jan. 13 is expected to begin in the second quarter of 2022 and be completed by the end of 2024, Exact Sciences associate director of corporate affairs Scott Larrivee said.

Exact Sciences Corp. (Nasdaq: EXAS), one of the largest public companies based in Wisconsin, said it plans to invest an additional $350 million in Madison facilities and hire at least 1,300 more Wisconsin employees by 2025.

The planned Exact Sciences Research and Development Center of Excellence will be at 5501 Endeavor Lane in Madison, next to the company’s corporate headquarters. Exact Sciences refers to this area in the University Research Park as its Innovation Campus.

Click here to read the full article.